IMVT Immunovant, Inc.
Nasdaq · SEC CIK 1764013 · EDGAR
- Bought, last 12 months
- $350.00M 1 purchases by 1 insiders
- Sold, last 12 months
- $15.93M 38 sales by 10 insiders
- Filings on record
- 265 since 2021-08-02, latest 2026-08-28 16:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| Fromkin Andrew J. | Dir | — | $7.96M |
| Stout Jay S | CTO | — | $2.27M |
| Gloria Melanie | COO | — | $1.60M |
| Girao Tiago | CFO | — | $1.41M |
| Van Tuyl Christopher | CLO | — | $1.31M |
| Venker Eric | CEO, Dir | — | $461.8K |
| Pande Atul | Dir | — | $424.6K |
| Hughes Douglas J. | Dir | — | $348.7K |
| Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 274
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-18 | 2024-12-16 | IMVT | Van Tuyl Christopher | CLO | A - Grant | $0.00 | +110.0K | 110.0K | New | $0 |
| 2024-12-04 | 2024-12-02 | IMVT | Pande Atul | Dir | S - Sale | $28.54 | -7,750 | 86.7K | -8% | -$221.2K | |
| 2024-12-04 | 2024-12-02 | IMVT | Hughes Douglas J. | Dir | S - Sale | $28.54 | -5,425 | 119.6K | -4% | -$154.8K | |
| 2024-11-22 | 2024-11-20 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $25.45 | -3,353 | 361.8K | -0.9% | -$85.3K | |
| 2024-11-22 | 2024-11-20 | IMVT | Barnett Eva Renee | CFO | S - Sale | $25.45 | -4,174 | 331.2K | -1% | -$106.2K | |
| 2024-11-22 | 2024-11-20 | IMVT | Levine Mark S. | CLO | S - Sale | $25.45 | -3,650 | 319.2K | -1% | -$92.9K | |
| 2024-11-22 | 2024-11-20 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $25.45 | -16.7K | 978.1K | -2% | -$424.8K | |
| D | 2024-11-20 | 2024-11-18 | IMVT | Gloria Melanie | COO | A - Grant | $0.00 | +110.0K | 110.0K | New | $0 |
| 2024-10-25 | 2024-10-23 | IMVT | Stout Jay S | CTO | S - Sale | $29.53 | -2,740 | 142.2K | -2% | -$80.9K | |
| 2024-10-25 | 2024-10-23 | IMVT | Levine Mark S. | CLO | S - Sale | $29.53 | -4,361 | 322.9K | -1% | -$128.8K | |
| 2024-10-25 | 2024-10-23 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $29.53 | -3,189 | 135.0K | -2% | -$94.2K | |
| M | 2024-10-18 | 2024-10-16 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $28.79 | -3,188 | 365.7K | -0.9% | -$91.8K |
| 2024-10-18 | 2024-10-16 | IMVT | Barnett Eva Renee | CFO | S - Sale | $28.79 | -3,271 | 335.3K | -1.0% | -$94.2K | |
| 2024-10-18 | 2024-10-16 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $28.79 | -9,095 | 994.8K | -0.9% | -$261.8K | |
| 2024-10-18 | 2024-10-16 | IMVT | Levine Mark S. | CLO | S - Sale | $28.79 | -2,860 | 327.2K | -0.9% | -$82.3K | |
| 2024-10-11 | 2024-10-09 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $29.56 | -4,460 | 1.00M | -0.4% | -$131.8K | |
| 2024-10-11 | 2024-10-09 | IMVT | Barnett Eva Renee | CFO | S - Sale | $29.56 | -5,162 | 338.6K | -2% | -$152.6K | |
| M | 2024-08-23 | 2024-08-21 | IMVT | Barnett Eva Renee | CFO | S - Sale | $31.86 | -3,768 | 343.8K | -1% | -$120.0K |
| M | 2024-08-23 | 2024-08-21 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $31.86 | -3,027 | 368.3K | -0.8% | -$96.4K |
| M | 2024-08-23 | 2024-08-21 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $31.86 | -3,027 | 441.1K | -0.7% | -$96.4K |
| M | 2024-08-23 | 2024-08-21 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $31.86 | -15.1K | 1.01M | -1% | -$480.1K |
| M | 2024-08-23 | 2024-08-21 | IMVT | Levine Mark S. | CLO | S - Sale | $31.86 | -3,295 | 330.2K | -1.0% | -$105.0K |
| 2024-07-26 | 2024-07-24 | IMVT | Stout Jay S | CTO | S - Sale | $27.76 | -2,813 | 144.9K | -2% | -$78.1K | |
| 2024-07-26 | 2024-07-24 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $27.76 | -3,456 | 138.2K | -2% | -$95.9K | |
| 2024-07-26 | 2024-07-24 | IMVT | Levine Mark S. | CLO | S - Sale | $27.76 | -4,015 | 333.4K | -1% | -$111.5K | |
| M | 2024-07-19 | 2024-07-17 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $29.69 | -8,685 | 1.02M | -0.8% | -$257.9K |
| M | 2024-07-19 | 2024-07-17 | IMVT | Levine Mark S. | CLO | S - Sale | $29.69 | -2,505 | 337.4K | -0.7% | -$74.4K |
| M | 2024-07-19 | 2024-07-17 | IMVT | Barnett Eva Renee | CFO | S - Sale | $29.69 | -3,123 | 347.7K | -0.9% | -$92.7K |
| M | 2024-07-19 | 2024-07-17 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $29.69 | -2,867 | 444.2K | -0.6% | -$85.1K |
| M | 2024-07-19 | 2024-07-17 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $29.69 | -3,044 | 371.9K | -0.8% | -$90.4K |
| 2024-07-10 | 2024-07-09 | IMVT | Barnett Eva Renee | CFO | S - Sale | $28.06 | -4,747 | 350.7K | -1% | -$133.2K | |
| 2024-07-10 | 2024-07-09 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $28.06 | -4,619 | 1.03M | -0.4% | -$129.6K | |
| 2024-07-10 | 2024-07-09 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $28.06 | -1,527 | 446.9K | -0.3% | -$42.8K | |
| 2024-05-24 | 2024-05-22 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $29.65 | -16.2K | 1.04M | -2% | -$479.2K | |
| 2024-05-24 | 2024-05-22 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $29.65 | -3,247 | 448.4K | -0.7% | -$96.3K | |
| 2024-05-24 | 2024-05-22 | IMVT | Barnett Eva Renee | CFO | S - Sale | $29.65 | -4,042 | 355.4K | -1% | -$119.8K | |
| 2024-05-24 | 2024-05-22 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $29.65 | -3,247 | 374.4K | -0.9% | -$96.3K | |
| 2024-05-24 | 2024-05-22 | IMVT | Levine Mark S. | CLO | S - Sale | $29.65 | -3,242 | 339.9K | -0.9% | -$96.1K | |
| 2024-04-26 | 2024-04-24 | IMVT | Levine Mark S. | CLO | S - Sale | $28.90 | -3,963 | 343.2K | -1% | -$114.5K | |
| 2024-04-26 | 2024-04-24 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $28.90 | -3,261 | 141.6K | -2% | -$94.2K | |
| 2024-04-26 | 2024-04-24 | IMVT | Stout Jay S | CTO | S - Sale | $28.90 | -7,239 | 147.7K | -5% | -$209.2K | |
| M | 2024-04-19 | 2024-04-17 | IMVT | Barnett Eva Renee | CFO | S - Sale | $29.06 | -12.3K | 359.5K | -3% | -$356.0K |
| M | 2024-04-19 | 2024-04-17 | IMVT | Levine Mark S. | CLO | S - Sale | $29.06 | -9,827 | 347.1K | -3% | -$285.6K |
| M | 2024-04-19 | 2024-04-17 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $29.06 | -34.1K | 1.06M | -3% | -$990.3K |
| M | 2024-04-19 | 2024-04-17 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $29.06 | -8,280 | 377.6K | -2% | -$240.6K |
| M | 2024-04-19 | 2024-04-17 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $29.06 | -10.1K | 453.9K | -2% | -$293.9K |
| 2024-04-10 | 2024-04-09 | IMVT | Barnett Eva Renee | CFO | S - Sale | $31.18 | -3,689 | 371.7K | -1.0% | -$115.0K | |
| 2024-04-10 | 2024-04-09 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $31.18 | -4,807 | 1.09M | -0.4% | -$149.9K | |
| 2024-04-10 | 2024-04-09 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $31.18 | -1,053 | 461.7K | -0.2% | -$32.8K | |
| D | 2024-04-04 | 2024-04-02 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +11.3K | 121.1K | +10% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Stout Jay S | CTO | A - Grant | $0.00 | +55.0K | 155.0K | +55% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Levine Mark S. | CLO | A - Grant | $0.00 | +55.0K | 356.9K | +18% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Butchko Julia G. | Chief Development Off | A - Grant | $0.00 | +55.0K | 462.8K | +13% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Barnett Eva Renee | CFO | A - Grant | $0.00 | +55.0K | 375.4K | +17% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Geffner Michael | Chief Medical Off | A - Grant | $0.00 | +55.0K | 144.9K | +61% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Hughes Douglas J. | Dir | A - Grant | $0.00 | +11.3K | 125.0K | +10% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +160.5K | 1.09M | +17% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Torti Frank | Dir | A - Grant | $0.00 | +120.4K | 635.7K | +23% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +11.3K | 99.9K | +13% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Pande Atul | Dir | A - Grant | $0.00 | +11.3K | 94.4K | +14% | $0 |
| D | 2024-04-04 | 2024-04-02 | IMVT | Macias William L. | Chief Medical Off | A - Grant | $0.00 | +55.0K | 385.9K | +17% | $0 |
| 2024-02-23 | 2024-02-22 | IMVT | Levine Mark S. | CLO | S - Sale | $36.15 | -2,134 | 302.0K | -0.7% | -$77.1K | |
| 2024-02-23 | 2024-02-22 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $36.15 | -2,146 | 407.8K | -0.5% | -$77.6K | |
| 2024-02-23 | 2024-02-22 | IMVT | Barnett Eva Renee | CFO | S - Sale | $36.15 | -2,930 | 320.4K | -0.9% | -$105.9K | |
| 2024-02-23 | 2024-02-22 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $36.15 | -2,221 | 331.0K | -0.7% | -$80.3K | |
| 2024-02-23 | 2024-02-22 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $36.15 | -13.5K | 931.2K | -1% | -$486.4K | |
| M | 2024-01-29 | 2024-01-26 | IMVT | Levine Mark S. | CLO | S - Sale | $37.92 | -3,027 | 304.1K | -1.0% | -$114.8K |
| M | 2024-01-29 | 2024-01-26 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $37.92 | -10.1K | 90.1K | -10% | -$383.0K |
| 2024-01-19 | 2024-01-18 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $41.03 | -424 | 333.2K | -0.1% | -$17.4K | |
| M | 2024-01-12 | 2024-01-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $41.83 | -3,515 | 323.4K | -1% | -$147.0K |
| 2024-01-09 | 2024-01-05 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $38.59 | -3,824 | 944.7K | -0.4% | -$147.6K | |
| 2024-01-09 | 2024-01-05 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $38.59 | -1,297 | 410.0K | -0.3% | -$50.1K | |
| M | 2023-12-05 | 2023-12-01 | IMVT | Pande Atul | Dir | S - Sale | $39.73 | -12.3K | 83.2K | -13% | -$490.7K |
| M | 2023-12-05 | 2023-12-01 | IMVT | MIGAUSKY GEORGE V | Dir | S - Sale | $39.73 | -12.7K | 109.8K | -10% | -$504.6K |
| M | 2023-12-05 | 2023-12-01 | IMVT | Fromkin Andrew J. | Dir | S - Sale | $39.73 | -12.3K | 93.4K | -12% | -$490.7K |
| M | 2023-11-24 | 2023-11-22 | IMVT | Barnett Eva Renee | CFO | S - Sale | $32.78 | -4,055 | 327.0K | -1% | -$132.9K |
| M | 2023-11-24 | 2023-11-22 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $32.78 | -16.2K | 948.5K | -2% | -$531.6K |
| M | 2023-11-24 | 2023-11-22 | IMVT | Levine Mark S. | CLO | S - Sale | $32.78 | -3,252 | 307.1K | -1% | -$106.6K |
| M | 2023-11-24 | 2023-11-22 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $32.78 | -3,265 | 333.6K | -1.0% | -$107.0K |
| M | 2023-11-24 | 2023-11-22 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $32.78 | -3,265 | 411.4K | -0.8% | -$107.0K |
| 2023-10-27 | 2023-10-25 | IMVT | Levine Mark S. | CLO | S - Sale | $34.66 | -4,107 | 310.4K | -1% | -$142.3K | |
| 2023-10-20 | 2023-10-19 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $36.80 | -530 | 336.9K | -0.2% | -$19.5K | |
| 2023-10-11 | 2023-10-10 | IMVT | Barnett Eva Renee | CFO | S - Sale | $36.92 | -4,557 | 330.9K | -1% | -$168.2K | |
| M | 2023-10-06 | 2023-10-05 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $36.24 | -5,239 | 969.1K | -0.5% | -$189.9K |
| M | 2023-10-06 | 2023-10-05 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $36.24 | -1,735 | 416.0K | -0.4% | -$62.9K |
| 2023-10-04 | 2023-10-02 | IMVT | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $38.00 | +1.53M | 79.81M | +2% | +$58.00M | |
| 2023-10-04 | 2023-10-02 | IMVT | Roivant Sciences Ltd. | Dir, 10% | A - Grant | $38.00 | +4.47M | 78.28M | +6% | +$170.00M | |
| M | 2023-09-01 | 2023-08-30 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $22.02 | -56.8K | 975.9K | -5% | -$1.25M |
| M | 2023-08-25 | 2023-08-24 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $20.30 | -12.3K | 416.3K | -3% | -$250.4K |
| M | 2023-08-25 | 2023-08-24 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $20.30 | -12.3K | 337.4K | -4% | -$250.4K |
| M | 2023-08-25 | 2023-08-24 | IMVT | Barnett Eva Renee | CFO | S - Sale | $20.30 | -14.4K | 335.5K | -4% | -$292.0K |
| M | 2023-08-25 | 2023-08-24 | IMVT | Levine Mark S. | CLO | S - Sale | $20.30 | -12.3K | 314.5K | -4% | -$249.4K |
| M | 2023-08-16 | 2023-08-14 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $21.42 | -103.1K | 1.03M | -9% | -$2.21M |
| 2023-08-08 | 2023-08-07 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $21.73 | -101.3K | 1.13M | -8% | -$2.20M | |
| 2023-07-27 | 2023-07-26 | IMVT | Levine Mark S. | CLO | S - Sale | $21.63 | -3,917 | 326.8K | -1% | -$84.7K | |
| 2023-07-20 | 2023-07-19 | IMVT | Barnett Eva Renee | CFO | S - Sale | $24.94 | -2,725 | 349.9K | -0.8% | -$68.0K | |
| 2023-07-20 | 2023-07-19 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $24.94 | -426 | 349.7K | -0.1% | -$10.6K | |
| 2023-07-13 | 2023-07-12 | IMVT | Butchko Julia G. | Chief Development Off | S - Sale | $19.73 | -1,470 | 428.6K | -0.3% | -$29.0K | |
| 2023-07-13 | 2023-07-12 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $19.73 | -3,233 | 1.23M | -0.3% | -$63.8K | |
| 2023-04-26 | 2023-04-25 | IMVT | Levine Mark S. | CLO | S - Sale | $16.29 | -2,633 | 330.7K | -0.8% | -$42.9K |
Purchase Sale Sale after option exercise All abbreviations